SlideShare a Scribd company logo
1 of 32
JAFAR ALSAID M.B.ChB. MD. FASN. FACP.
Chair of the Middle East and North Africa Advisory Group. ISH
Nephrology Consultant. Ochsner Health System. USA
Nephrology and Internal Medicine Consultant. Bahrain
jafaralsaid@gmail.com
2020 INTERNATIONAL SOCIETY OF HYPERTESION
GLOBAL HYPERTENSION PRACTICE GUIDLINES.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
1
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
2
Introduction
Hypertension
• Leading cause of death.
• 10.4 million death annually.
• Affect 1.39 Billion people.
• More in the low-income countries.
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global disparities of hypertension prevalence
and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–450.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
3
Awareness
67%
38%
High Income Low and Middle Income
Beaney T, Burrell LM, Castillo RR, Charchar FJ, Cro S, Damasceno A, Kruger R, Nilsson PM, Prabhakaran D, Ramirez AJ, et al,
MMM Investigators. May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood
pressure by the International Society of Hypertension. Eur Heart J. 2019;40:2006–2017.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
4
INTERNATIONAL SOCIETY OF HYPERTENSION
HYPERTENSION GLOBAL AWARENESS CAMPAGN
MAY MEASUREMENT MONTH INITIATIVE
MMM
Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, Charchar FJ, Damasceno A, Kruger R, Lackland DT,
et al. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health.
2018;6:e736-e743.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
5
Worldwide Practice Guidelines
•High Income.
•Middle Income.
•Low income.
ESSENTIAL
OPTIMAL
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
6
Obstacles for Low-income countries:
• No regional guidelines.
• Lack of data in low-income countries.
• Availability of multiple guidelines.
• Difficulties in following high income countries guidelines.
• Guidelines generated reflect the best practice for that
population.
• Lack of trained health facilities.
• Low access to basic BP devices.
Poulter NR, Castillo R, Charchar FJ, Schlaich MP, Schutte AE, Tomaszewski M, Touyz RM, Wang JG. Are the American Heart
Association/ American College of Cardiology high blood pressure guidelines fit for global purpose?: Thoughts from the
International Society of Hypertension. Hypertension. 2018;72:260–262.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
7
HYPERTENSION DEFINITION
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
8
Criteria for Hypertension Based on Office, Ambulatory
(ABPM)& Home Blood Pressure (HBPM) Measurement
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
9
Classification of Hypertension Based on Office
Blood Pressure (BP) Measurement
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
10
Measuring BP:
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
11
Points to consider on Measuring BP
• Repeat the reading.
• Both arms are checked. >10mmHg is significant.
• Standing BP. In Orthostatic symptoms.
• BP Cuff size.
• Unattended Office BP.
• Out of office BP measurements.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
13
White Coat & Masked Hypertension
White Coat Masked
% 10-30 10-15
Clinic/Hospital Elevated Normal
Out of office BP Normal Elevated
CV risk Moderate Like HTN
Diagnosis ABPM/Home
Management Lifestyle Lifestyle + Med.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et
al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the Management Of Arterial
Hypertension of the European Society of Cardiology and the
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
14
Diagnosis
•History.
•CV risk factors.
•Physical Exam.
•Labs.
•Specific investigation.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
15
CV risk factors with HTN
• DM 15-20%.
• Elevated LDL and Triglyce. 30%.
• Over wt. 40%.
• Hyperuricemia. 25%
• Metabolic syndrome. 40%
• Unhealthy lifestyle.
• Family history.
• Age/Gender/Race.
• Chronic Inflammation.
Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of
population health data. Lancet. 2006;367:1747–1757.
Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings
and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992;152:56–64
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
16
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al.
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the Management Of Arterial
Hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
17
Hypertension
Mediated
Organ
Damage
Brain: Stroke, Microinfarct, Bleed or
Atrophy.
Heart: LVH. Diastolic or systolic dysfunction.
Kidney: Proteinuria or decreased eGFR.
Vascular system: Central or Peripheral.
Eye: Retinal changes. Papilledema.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
18
Basic Hypertensive Modifiable Organ Damage
Required Tests.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
19
Specific Investigations
• ECHO.
• Carotid Ultrasound.
• Fundoscopy.
• Kidney and adrenal imaging.
• Brain MRI/CT.
• Hormonal assay.
• Uric Acid.
• Liver function test.
• Ankle Brachial index.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
20
Medications
Affecting BP
Medications Increase Syst./Dias.
NSAID. 3/1 mmHg.
Oral Contraceptives. 6/3 mmHg.
Antidepressants. 2/1 mmHg.
Daily Acetaminophen 34% increase HTN
incident.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
21
Other
Medications
Affecting BP.
Steroids.
Anti Retroviral.
Sympathomimetics.
Erythropoietin Stim.
Antimigraine.
Calcineurin inh.
Antiangiogenisis and Kinase inh.
11 Beta OH steroid dehydrogenase.
Herbal: Alcohol, Ginseng high dose, Liquirice.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
22
Blood
Pressure
Variations
With Stress.
Lack of Sleep.
Pain.
Substance abuse.
Seasonal.
Altitude.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
23
HTN stage
CV risk
factors
Socioeco.
status
Lifestyle
Medical
History
Target
Organ
Damage
Management
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
24
Lifestyle
Modifications
Salt intake. 2-4 gm/day.
Healthy diet.
Healthy drinks.
Wt. Reduction.
Smoke Cessation.
Limiting Alcohol.
Regular Exercise.
Control stress.
Get Proper sleep.
Control Pain.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
25
Pharmacological
Treatment
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
26
Target Office BP Treatment
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
27
Ideal Characteristics of Drug Treatment
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
28
ISH Core Drug Therapy
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
29
Adherence
to
Medication
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
30
Other
Aspects
Common Comorbidity.
Pregnancy.
HTN Crisis.
Secondary HTN.
Summary Diagrams.
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
31
Educate, discuss and communicate
with your patient
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
32
Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION
CONFERENCE NOV. 2021
33

More Related Content

What's hot

Heart Failure Preserved EF
Heart Failure Preserved EF Heart Failure Preserved EF
Heart Failure Preserved EF Han Naung Tun
 
Hypertension Management - ESC/ESH 2018 guidelines
Hypertension Management - ESC/ESH 2018 guidelinesHypertension Management - ESC/ESH 2018 guidelines
Hypertension Management - ESC/ESH 2018 guidelinesPardhuBharath1
 
Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Praveen Nagula
 
Sprint trial
Sprint trialSprint trial
Sprint trialIqbal Dar
 
New Treatments in HFrEF
New Treatments in HFrEFNew Treatments in HFrEF
New Treatments in HFrEFDuke Heart
 
Acs focus on dapt
Acs focus on daptAcs focus on dapt
Acs focus on daptmagdy elmasry
 
What’s new in Lipidology, Lessons from “recent guidelines“
What’s new in Lipidology, Lessons from “recent guidelines“What’s new in Lipidology, Lessons from “recent guidelines“
What’s new in Lipidology, Lessons from “recent guidelines“Arindam Pande
 
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKDCARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKDMohd Tariq Ali
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary interventionRamachandra Barik
 
New Perspectives Of Coronary Heart Disease In Young Adults
New Perspectives Of Coronary Heart Disease In Young AdultsNew Perspectives Of Coronary Heart Disease In Young Adults
New Perspectives Of Coronary Heart Disease In Young Adultsahvc0858
 
Antiplatelet therapy
Antiplatelet therapyAntiplatelet therapy
Antiplatelet therapyArindam Pande
 
Dr Vivek Baliga - Diastolic heart failure - A complete overview
Dr Vivek Baliga - Diastolic heart failure - A complete overviewDr Vivek Baliga - Diastolic heart failure - A complete overview
Dr Vivek Baliga - Diastolic heart failure - A complete overviewDr Vivek Baliga
 
Diagnosis & Management of Resistant Hypertension
Diagnosis & Management of Resistant HypertensionDiagnosis & Management of Resistant Hypertension
Diagnosis & Management of Resistant HypertensionDr.Vinod Sharma
 
Vymada - Sacubitril & Valsartan (ARNI) For Heart Failure
Vymada - Sacubitril & Valsartan (ARNI) For Heart FailureVymada - Sacubitril & Valsartan (ARNI) For Heart Failure
Vymada - Sacubitril & Valsartan (ARNI) For Heart FailureDr Sunny Kumar Gupta
 
Current management of hypertension DR. ANKIT JAIN AIIMS
Current management of hypertension DR. ANKIT JAIN AIIMSCurrent management of hypertension DR. ANKIT JAIN AIIMS
Current management of hypertension DR. ANKIT JAIN AIIMSAnkit Jain
 
Sacubitril Valsartan in Heart failure and Congenital heart disease
Sacubitril Valsartan in Heart failure and Congenital heart diseaseSacubitril Valsartan in Heart failure and Congenital heart disease
Sacubitril Valsartan in Heart failure and Congenital heart diseasepankaj bhosale
 

What's hot (20)

Heart Failure Preserved EF
Heart Failure Preserved EF Heart Failure Preserved EF
Heart Failure Preserved EF
 
Hypertension Management - ESC/ESH 2018 guidelines
Hypertension Management - ESC/ESH 2018 guidelinesHypertension Management - ESC/ESH 2018 guidelines
Hypertension Management - ESC/ESH 2018 guidelines
 
Heart failure management - role of arni
Heart failure management - role of arniHeart failure management - role of arni
Heart failure management - role of arni
 
Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates
 
Sprint trial
Sprint trialSprint trial
Sprint trial
 
New Treatments in HFrEF
New Treatments in HFrEFNew Treatments in HFrEF
New Treatments in HFrEF
 
Acs focus on dapt
Acs focus on daptAcs focus on dapt
Acs focus on dapt
 
Ambulatory BP monitoring
Ambulatory BP monitoringAmbulatory BP monitoring
Ambulatory BP monitoring
 
What’s new in Lipidology, Lessons from “recent guidelines“
What’s new in Lipidology, Lessons from “recent guidelines“What’s new in Lipidology, Lessons from “recent guidelines“
What’s new in Lipidology, Lessons from “recent guidelines“
 
world Hypertension day 2023.pdf
world Hypertension  day 2023.pdfworld Hypertension  day 2023.pdf
world Hypertension day 2023.pdf
 
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKDCARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
CARDIAC COMPLICATIONS & ITS MANAGEMENT OF CKD
 
Primary Percutaneus coronary intervention
Primary Percutaneus coronary interventionPrimary Percutaneus coronary intervention
Primary Percutaneus coronary intervention
 
New Perspectives Of Coronary Heart Disease In Young Adults
New Perspectives Of Coronary Heart Disease In Young AdultsNew Perspectives Of Coronary Heart Disease In Young Adults
New Perspectives Of Coronary Heart Disease In Young Adults
 
Hypertension management 2018
Hypertension  management 2018Hypertension  management 2018
Hypertension management 2018
 
Antiplatelet therapy
Antiplatelet therapyAntiplatelet therapy
Antiplatelet therapy
 
Dr Vivek Baliga - Diastolic heart failure - A complete overview
Dr Vivek Baliga - Diastolic heart failure - A complete overviewDr Vivek Baliga - Diastolic heart failure - A complete overview
Dr Vivek Baliga - Diastolic heart failure - A complete overview
 
Diagnosis & Management of Resistant Hypertension
Diagnosis & Management of Resistant HypertensionDiagnosis & Management of Resistant Hypertension
Diagnosis & Management of Resistant Hypertension
 
Vymada - Sacubitril & Valsartan (ARNI) For Heart Failure
Vymada - Sacubitril & Valsartan (ARNI) For Heart FailureVymada - Sacubitril & Valsartan (ARNI) For Heart Failure
Vymada - Sacubitril & Valsartan (ARNI) For Heart Failure
 
Current management of hypertension DR. ANKIT JAIN AIIMS
Current management of hypertension DR. ANKIT JAIN AIIMSCurrent management of hypertension DR. ANKIT JAIN AIIMS
Current management of hypertension DR. ANKIT JAIN AIIMS
 
Sacubitril Valsartan in Heart failure and Congenital heart disease
Sacubitril Valsartan in Heart failure and Congenital heart diseaseSacubitril Valsartan in Heart failure and Congenital heart disease
Sacubitril Valsartan in Heart failure and Congenital heart disease
 

Similar to International Society of Hypertension 2020 guidlines

Uric acid and htn saudi htn conference final 3
Uric acid and htn saudi  htn conference final 3Uric acid and htn saudi  htn conference final 3
Uric acid and htn saudi htn conference final 3JAFAR ALSAID
 
Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...
Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...
Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...James Underberg
 
2022 Hypertension Lecture (Updated Guidelines).pdf
2022 Hypertension Lecture (Updated Guidelines).pdf2022 Hypertension Lecture (Updated Guidelines).pdf
2022 Hypertension Lecture (Updated Guidelines).pdfMeccar Moniem Elino
 
Why should we measure endothelial function
Why should we measure endothelial functionWhy should we measure endothelial function
Why should we measure endothelial functionEndothelix
 
Hypertension in Developing Countries 3
Hypertension in Developing Countries 3Hypertension in Developing Countries 3
Hypertension in Developing Countries 3JAFAR ALSAID
 
HYPERTENSION (2015_05_23 01_19_47 UTC).ppt
HYPERTENSION (2015_05_23 01_19_47 UTC).pptHYPERTENSION (2015_05_23 01_19_47 UTC).ppt
HYPERTENSION (2015_05_23 01_19_47 UTC).pptWilliamKaye7
 
Advancingdialysis.org 2017 ASN Sponsored Symposium Presentation
Advancingdialysis.org 2017 ASN Sponsored Symposium PresentationAdvancingdialysis.org 2017 ASN Sponsored Symposium Presentation
Advancingdialysis.org 2017 ASN Sponsored Symposium PresentationAdvancingDialysis.org
 
Heart Failure biomarkers
Heart Failure biomarkersHeart Failure biomarkers
Heart Failure biomarkersdrucsamal
 
COMPARISON OF RISK FACTORS IN YOUNG ADULTS WITH OLDER ADULT PATIENTS WITH REC...
COMPARISON OF RISK FACTORS IN YOUNG ADULTS WITH OLDER ADULT PATIENTS WITH REC...COMPARISON OF RISK FACTORS IN YOUNG ADULTS WITH OLDER ADULT PATIENTS WITH REC...
COMPARISON OF RISK FACTORS IN YOUNG ADULTS WITH OLDER ADULT PATIENTS WITH REC...DrSajadAhmedBadvi
 
European Society of Hypertension 2013 Hypertension guidelines presentation in...
European Society of Hypertension 2013 Hypertension guidelines presentation in...European Society of Hypertension 2013 Hypertension guidelines presentation in...
European Society of Hypertension 2013 Hypertension guidelines presentation in...JAFAR ALSAID
 
Hypertension among teenage years 28
Hypertension among teenage years 28Hypertension among teenage years 28
Hypertension among teenage years 28JAFAR ALSAID
 
Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021Duke Heart
 
2017 AHA/ACC Hypertension guideline summary
2017 AHA/ACC Hypertension guideline summary2017 AHA/ACC Hypertension guideline summary
2017 AHA/ACC Hypertension guideline summaryYung-Tsai Chu
 
James Januzzi, Assessment of Heart Failure: Early Identification and Across t...
James Januzzi, Assessment of Heart Failure: Early Identification and Across t...James Januzzi, Assessment of Heart Failure: Early Identification and Across t...
James Januzzi, Assessment of Heart Failure: Early Identification and Across t...Cleveland HeartLab, Inc.
 
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...sezarublack1
 
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...RizkiFebriyani2
 
clopidogril and ACS
clopidogril and ACSclopidogril and ACS
clopidogril and ACSMahmoud Yossof
 
Dyslipidemia & ayurveda
Dyslipidemia & ayurvedaDyslipidemia & ayurveda
Dyslipidemia & ayurvedaAmit Sharma
 

Similar to International Society of Hypertension 2020 guidlines (20)

Uric acid and htn saudi htn conference final 3
Uric acid and htn saudi  htn conference final 3Uric acid and htn saudi  htn conference final 3
Uric acid and htn saudi htn conference final 3
 
Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...
Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...
Are All FH patients the same ? Cardiovascular Risk Assessment in Familial Hyp...
 
2022 Hypertension Lecture (Updated Guidelines).pdf
2022 Hypertension Lecture (Updated Guidelines).pdf2022 Hypertension Lecture (Updated Guidelines).pdf
2022 Hypertension Lecture (Updated Guidelines).pdf
 
Improving heart health in harlem
Improving heart health in harlemImproving heart health in harlem
Improving heart health in harlem
 
Why should we measure endothelial function
Why should we measure endothelial functionWhy should we measure endothelial function
Why should we measure endothelial function
 
Hypertension in Developing Countries 3
Hypertension in Developing Countries 3Hypertension in Developing Countries 3
Hypertension in Developing Countries 3
 
HYPERTENSION (2015_05_23 01_19_47 UTC).ppt
HYPERTENSION (2015_05_23 01_19_47 UTC).pptHYPERTENSION (2015_05_23 01_19_47 UTC).ppt
HYPERTENSION (2015_05_23 01_19_47 UTC).ppt
 
Advancingdialysis.org 2017 ASN Sponsored Symposium Presentation
Advancingdialysis.org 2017 ASN Sponsored Symposium PresentationAdvancingdialysis.org 2017 ASN Sponsored Symposium Presentation
Advancingdialysis.org 2017 ASN Sponsored Symposium Presentation
 
Heart Failure biomarkers
Heart Failure biomarkersHeart Failure biomarkers
Heart Failure biomarkers
 
COMPARISON OF RISK FACTORS IN YOUNG ADULTS WITH OLDER ADULT PATIENTS WITH REC...
COMPARISON OF RISK FACTORS IN YOUNG ADULTS WITH OLDER ADULT PATIENTS WITH REC...COMPARISON OF RISK FACTORS IN YOUNG ADULTS WITH OLDER ADULT PATIENTS WITH REC...
COMPARISON OF RISK FACTORS IN YOUNG ADULTS WITH OLDER ADULT PATIENTS WITH REC...
 
European Society of Hypertension 2013 Hypertension guidelines presentation in...
European Society of Hypertension 2013 Hypertension guidelines presentation in...European Society of Hypertension 2013 Hypertension guidelines presentation in...
European Society of Hypertension 2013 Hypertension guidelines presentation in...
 
Hypertension among teenage years 28
Hypertension among teenage years 28Hypertension among teenage years 28
Hypertension among teenage years 28
 
Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021Pulmonary Hypertension Basics 2021
Pulmonary Hypertension Basics 2021
 
2017 AHA/ACC Hypertension guideline summary
2017 AHA/ACC Hypertension guideline summary2017 AHA/ACC Hypertension guideline summary
2017 AHA/ACC Hypertension guideline summary
 
James Januzzi, Assessment of Heart Failure: Early Identification and Across t...
James Januzzi, Assessment of Heart Failure: Early Identification and Across t...James Januzzi, Assessment of Heart Failure: Early Identification and Across t...
James Januzzi, Assessment of Heart Failure: Early Identification and Across t...
 
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
 
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
2022 Guideline for the Management of Patients With Spontaneous ICH Clinical U...
 
ckd
ckdckd
ckd
 
clopidogril and ACS
clopidogril and ACSclopidogril and ACS
clopidogril and ACS
 
Dyslipidemia & ayurveda
Dyslipidemia & ayurvedaDyslipidemia & ayurveda
Dyslipidemia & ayurveda
 

More from JAFAR ALSAID

Hypertension During Disaster 4.pptx
Hypertension During Disaster 4.pptxHypertension During Disaster 4.pptx
Hypertension During Disaster 4.pptxJAFAR ALSAID
 
HTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptxHTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptxJAFAR ALSAID
 
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...JAFAR ALSAID
 
Renal interstitial fibrosis and its associated independent clinical factors.docx
Renal interstitial fibrosis and its associated independent clinical factors.docxRenal interstitial fibrosis and its associated independent clinical factors.docx
Renal interstitial fibrosis and its associated independent clinical factors.docxJAFAR ALSAID
 
Hypertension in Middle East and North Africa region
Hypertension in Middle East and North Africa regionHypertension in Middle East and North Africa region
Hypertension in Middle East and North Africa regionJAFAR ALSAID
 
Ultrasound basics for Nephrologists.pptx
Ultrasound basics  for Nephrologists.pptxUltrasound basics  for Nephrologists.pptx
Ultrasound basics for Nephrologists.pptxJAFAR ALSAID
 
Uremic Leontiasis Ossea
Uremic Leontiasis OsseaUremic Leontiasis Ossea
Uremic Leontiasis OsseaJAFAR ALSAID
 
The differenece betweeen central and peripheral Blood pressure and its clinic...
The differenece betweeen central and peripheral Blood pressure and its clinic...The differenece betweeen central and peripheral Blood pressure and its clinic...
The differenece betweeen central and peripheral Blood pressure and its clinic...JAFAR ALSAID
 
Hemodialysis catheter related infection
Hemodialysis catheter related infection Hemodialysis catheter related infection
Hemodialysis catheter related infection JAFAR ALSAID
 
Hemodialysis catheter related infection 5
Hemodialysis catheter related infection 5Hemodialysis catheter related infection 5
Hemodialysis catheter related infection 5JAFAR ALSAID
 
Hemodialysis orders part ii
Hemodialysis orders part iiHemodialysis orders part ii
Hemodialysis orders part iiJAFAR ALSAID
 
Hemodialysis orders part 1
Hemodialysis orders part 1Hemodialysis orders part 1
Hemodialysis orders part 1JAFAR ALSAID
 
Kidney involvement in COVID-19
Kidney involvement in COVID-19Kidney involvement in COVID-19
Kidney involvement in COVID-19JAFAR ALSAID
 
Hypertension and COVID-19 link
Hypertension and COVID-19 linkHypertension and COVID-19 link
Hypertension and COVID-19 linkJAFAR ALSAID
 
Outcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection controlOutcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection controlJAFAR ALSAID
 
HTN among ESRD patients Current Review
HTN among ESRD patients Current ReviewHTN among ESRD patients Current Review
HTN among ESRD patients Current ReviewJAFAR ALSAID
 
Hypertension definition 3
Hypertension definition 3Hypertension definition 3
Hypertension definition 3JAFAR ALSAID
 
Diabetic Nephropathy Review
Diabetic Nephropathy ReviewDiabetic Nephropathy Review
Diabetic Nephropathy ReviewJAFAR ALSAID
 
Central Blood Pressure and its clinical implications
Central Blood Pressure and its clinical implicationsCentral Blood Pressure and its clinical implications
Central Blood Pressure and its clinical implicationsJAFAR ALSAID
 
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...JAFAR ALSAID
 

More from JAFAR ALSAID (20)

Hypertension During Disaster 4.pptx
Hypertension During Disaster 4.pptxHypertension During Disaster 4.pptx
Hypertension During Disaster 4.pptx
 
HTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptxHTN Among ESRD Patients Cardiology meeting .pptx
HTN Among ESRD Patients Cardiology meeting .pptx
 
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...
Final Ultrasound measured renal parenchyhmal thickness and sinus fat and thei...
 
Renal interstitial fibrosis and its associated independent clinical factors.docx
Renal interstitial fibrosis and its associated independent clinical factors.docxRenal interstitial fibrosis and its associated independent clinical factors.docx
Renal interstitial fibrosis and its associated independent clinical factors.docx
 
Hypertension in Middle East and North Africa region
Hypertension in Middle East and North Africa regionHypertension in Middle East and North Africa region
Hypertension in Middle East and North Africa region
 
Ultrasound basics for Nephrologists.pptx
Ultrasound basics  for Nephrologists.pptxUltrasound basics  for Nephrologists.pptx
Ultrasound basics for Nephrologists.pptx
 
Uremic Leontiasis Ossea
Uremic Leontiasis OsseaUremic Leontiasis Ossea
Uremic Leontiasis Ossea
 
The differenece betweeen central and peripheral Blood pressure and its clinic...
The differenece betweeen central and peripheral Blood pressure and its clinic...The differenece betweeen central and peripheral Blood pressure and its clinic...
The differenece betweeen central and peripheral Blood pressure and its clinic...
 
Hemodialysis catheter related infection
Hemodialysis catheter related infection Hemodialysis catheter related infection
Hemodialysis catheter related infection
 
Hemodialysis catheter related infection 5
Hemodialysis catheter related infection 5Hemodialysis catheter related infection 5
Hemodialysis catheter related infection 5
 
Hemodialysis orders part ii
Hemodialysis orders part iiHemodialysis orders part ii
Hemodialysis orders part ii
 
Hemodialysis orders part 1
Hemodialysis orders part 1Hemodialysis orders part 1
Hemodialysis orders part 1
 
Kidney involvement in COVID-19
Kidney involvement in COVID-19Kidney involvement in COVID-19
Kidney involvement in COVID-19
 
Hypertension and COVID-19 link
Hypertension and COVID-19 linkHypertension and COVID-19 link
Hypertension and COVID-19 link
 
Outcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection controlOutcome of 16 years of hemodialysis infection control
Outcome of 16 years of hemodialysis infection control
 
HTN among ESRD patients Current Review
HTN among ESRD patients Current ReviewHTN among ESRD patients Current Review
HTN among ESRD patients Current Review
 
Hypertension definition 3
Hypertension definition 3Hypertension definition 3
Hypertension definition 3
 
Diabetic Nephropathy Review
Diabetic Nephropathy ReviewDiabetic Nephropathy Review
Diabetic Nephropathy Review
 
Central Blood Pressure and its clinical implications
Central Blood Pressure and its clinical implicationsCentral Blood Pressure and its clinical implications
Central Blood Pressure and its clinical implications
 
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...
Proteinuria is it a risk marker or a therapeutic target for cardiovascular di...
 

Recently uploaded

Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
 
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Miss joya
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiNehru place Escorts
 
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowSonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowRiya Pathan
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaPooja Gupta
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...narwatsonia7
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliRewAs ALI
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipurparulsinha
 
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Nehru place Escorts
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...Miss joya
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Miss joya
 
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...Garima Khatri
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Servicemakika9823
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...Miss joya
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatorenarwatsonia7
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...Miss joya
 

Recently uploaded (20)

Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
 
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
Russian Call Girls in Pune Tanvi 9907093804 Short 1500 Night 6000 Best call g...
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
 
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Yelahanka Just Call 7001305949 Top Class Call Girl Service Available
 
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowSonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Sonagachi Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
 
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service NoidaCall Girls Service Noida Maya 9711199012 Independent Escort Service Noida
Call Girls Service Noida Maya 9711199012 Independent Escort Service Noida
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas Ali
 
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls JaipurCall Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
Call Girls Service Jaipur Grishma WhatsApp ❤8445551418 VIP Call Girls Jaipur
 
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
Russian Call Girls Chennai Madhuri 9907093804 Independent Call Girls Service ...
 
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
VIP Call Girls Pune Vani 9907093804 Short 1500 Night 6000 Best call girls Ser...
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
 
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Whitefield Just Call 7001305949 Top Class Call Girl Service Available
 
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
VIP Mumbai Call Girls Hiranandani Gardens Just Call 9920874524 with A/C Room ...
 
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls ServiceKesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
Kesar Bagh Call Girl Price 9548273370 , Lucknow Call Girls Service
 
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
College Call Girls Pune Mira 9907093804 Short 1500 Night 6000 Best call girls...
 
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service CoimbatoreCall Girl Coimbatore Prisha☎️  8250192130 Independent Escort Service Coimbatore
Call Girl Coimbatore Prisha☎️ 8250192130 Independent Escort Service Coimbatore
 
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
Russian Call Girls in Delhi Tanvi ➡️ 9711199012 💋📞 Independent Escort Service...
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
 

International Society of Hypertension 2020 guidlines

  • 1. JAFAR ALSAID M.B.ChB. MD. FASN. FACP. Chair of the Middle East and North Africa Advisory Group. ISH Nephrology Consultant. Ochsner Health System. USA Nephrology and Internal Medicine Consultant. Bahrain jafaralsaid@gmail.com 2020 INTERNATIONAL SOCIETY OF HYPERTESION GLOBAL HYPERTENSION PRACTICE GUIDLINES. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 1
  • 2. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 2
  • 3. Introduction Hypertension • Leading cause of death. • 10.4 million death annually. • Affect 1.39 Billion people. • More in the low-income countries. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–450. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 3
  • 4. Awareness 67% 38% High Income Low and Middle Income Beaney T, Burrell LM, Castillo RR, Charchar FJ, Cro S, Damasceno A, Kruger R, Nilsson PM, Prabhakaran D, Ramirez AJ, et al, MMM Investigators. May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. Eur Heart J. 2019;40:2006–2017. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 4
  • 5. INTERNATIONAL SOCIETY OF HYPERTENSION HYPERTENSION GLOBAL AWARENESS CAMPAGN MAY MEASUREMENT MONTH INITIATIVE MMM Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, Charchar FJ, Damasceno A, Kruger R, Lackland DT, et al. May Measurement Month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6:e736-e743. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 5
  • 6. Worldwide Practice Guidelines •High Income. •Middle Income. •Low income. ESSENTIAL OPTIMAL Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 6
  • 7. Obstacles for Low-income countries: • No regional guidelines. • Lack of data in low-income countries. • Availability of multiple guidelines. • Difficulties in following high income countries guidelines. • Guidelines generated reflect the best practice for that population. • Lack of trained health facilities. • Low access to basic BP devices. Poulter NR, Castillo R, Charchar FJ, Schlaich MP, Schutte AE, Tomaszewski M, Touyz RM, Wang JG. Are the American Heart Association/ American College of Cardiology high blood pressure guidelines fit for global purpose?: Thoughts from the International Society of Hypertension. Hypertension. 2018;72:260–262. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 7
  • 8. HYPERTENSION DEFINITION Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 8
  • 9. Criteria for Hypertension Based on Office, Ambulatory (ABPM)& Home Blood Pressure (HBPM) Measurement Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 9
  • 10. Classification of Hypertension Based on Office Blood Pressure (BP) Measurement Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 10
  • 11. Measuring BP: Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 11
  • 12. Points to consider on Measuring BP • Repeat the reading. • Both arms are checked. >10mmHg is significant. • Standing BP. In Orthostatic symptoms. • BP Cuff size. • Unattended Office BP. • Out of office BP measurements. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 13
  • 13. White Coat & Masked Hypertension White Coat Masked % 10-30 10-15 Clinic/Hospital Elevated Normal Out of office BP Normal Elevated CV risk Moderate Like HTN Diagnosis ABPM/Home Management Lifestyle Lifestyle + Med. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the Management Of Arterial Hypertension of the European Society of Cardiology and the Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 14
  • 14. Diagnosis •History. •CV risk factors. •Physical Exam. •Labs. •Specific investigation. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 15
  • 15. CV risk factors with HTN • DM 15-20%. • Elevated LDL and Triglyce. 30%. • Over wt. 40%. • Hyperuricemia. 25% • Metabolic syndrome. 40% • Unhealthy lifestyle. • Family history. • Age/Gender/Race. • Chronic Inflammation. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–1757. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992;152:56–64 Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 16
  • 16. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the Management Of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 17
  • 17. Hypertension Mediated Organ Damage Brain: Stroke, Microinfarct, Bleed or Atrophy. Heart: LVH. Diastolic or systolic dysfunction. Kidney: Proteinuria or decreased eGFR. Vascular system: Central or Peripheral. Eye: Retinal changes. Papilledema. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 18
  • 18. Basic Hypertensive Modifiable Organ Damage Required Tests. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 19
  • 19. Specific Investigations • ECHO. • Carotid Ultrasound. • Fundoscopy. • Kidney and adrenal imaging. • Brain MRI/CT. • Hormonal assay. • Uric Acid. • Liver function test. • Ankle Brachial index. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 20
  • 20. Medications Affecting BP Medications Increase Syst./Dias. NSAID. 3/1 mmHg. Oral Contraceptives. 6/3 mmHg. Antidepressants. 2/1 mmHg. Daily Acetaminophen 34% increase HTN incident. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 21
  • 21. Other Medications Affecting BP. Steroids. Anti Retroviral. Sympathomimetics. Erythropoietin Stim. Antimigraine. Calcineurin inh. Antiangiogenisis and Kinase inh. 11 Beta OH steroid dehydrogenase. Herbal: Alcohol, Ginseng high dose, Liquirice. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 22
  • 22. Blood Pressure Variations With Stress. Lack of Sleep. Pain. Substance abuse. Seasonal. Altitude. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 23
  • 23. HTN stage CV risk factors Socioeco. status Lifestyle Medical History Target Organ Damage Management Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 24
  • 24. Lifestyle Modifications Salt intake. 2-4 gm/day. Healthy diet. Healthy drinks. Wt. Reduction. Smoke Cessation. Limiting Alcohol. Regular Exercise. Control stress. Get Proper sleep. Control Pain. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 25
  • 25. Pharmacological Treatment Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 26
  • 26. Target Office BP Treatment Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 27
  • 27. Ideal Characteristics of Drug Treatment Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 28
  • 28. ISH Core Drug Therapy Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 29
  • 29. Adherence to Medication Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 30
  • 30. Other Aspects Common Comorbidity. Pregnancy. HTN Crisis. Secondary HTN. Summary Diagrams. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 31
  • 31. Educate, discuss and communicate with your patient Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 32
  • 32. Jafar Alsaid. M.B.ChB. MD. FASN. FACP IRAQI HYPERTENSION CONFERENCE NOV. 2021 33